ACB vs. CRON, THCX, WEED, GUD, FIRE, CRDL, OGI, EPI, ICC, and CPH
Should you be buying Aurora Cannabis stock or one of its competitors? The main competitors of Aurora Cannabis include Cronos Group (CRON), Hydropothecary (THCX), Canopy Growth (WEED), Knight Therapeutics (GUD), Supreme Cannabis (FIRE), Cardiol Therapeutics (CRDL), Organigram (OGI), ESSA Pharma (EPI), ICC Labs (ICC), and Cipher Pharmaceuticals (CPH). These companies are all part of the "drug manufacturers - specialty & generic" industry.
Aurora Cannabis (TSE:ACB) and Cronos Group (TSE:CRON) are both small-cap medical companies, but which is the superior stock? We will contrast the two companies based on the strength of their valuation, community ranking, risk, media sentiment, dividends, institutional ownership, analyst recommendations, profitability and earnings.
Aurora Cannabis has a beta of 2.65, suggesting that its share price is 165% more volatile than the S&P 500. Comparatively, Cronos Group has a beta of 1.08, suggesting that its share price is 8% more volatile than the S&P 500.
Aurora Cannabis has higher revenue and earnings than Cronos Group. Cronos Group is trading at a lower price-to-earnings ratio than Aurora Cannabis, indicating that it is currently the more affordable of the two stocks.
Aurora Cannabis has a net margin of 151.71% compared to Cronos Group's net margin of -61.31%. Cronos Group's return on equity of -4.99% beat Aurora Cannabis' return on equity.
Aurora Cannabis presently has a consensus target price of C$2.26, suggesting a potential downside of 71.12%. Cronos Group has a consensus target price of C$3.18, suggesting a potential downside of 5.92%. Given Cronos Group's higher probable upside, analysts plainly believe Cronos Group is more favorable than Aurora Cannabis.
Aurora Cannabis received 459 more outperform votes than Cronos Group when rated by MarketBeat users. Likewise, 63.16% of users gave Aurora Cannabis an outperform vote while only 50.74% of users gave Cronos Group an outperform vote.
9.0% of Aurora Cannabis shares are held by institutional investors. Comparatively, 15.9% of Cronos Group shares are held by institutional investors. 46.5% of Cronos Group shares are held by insiders. Strong institutional ownership is an indication that endowments, hedge funds and large money managers believe a company is poised for long-term growth.
In the previous week, Aurora Cannabis' average media sentiment score of 0.00 equaled Cronos Group'saverage media sentiment score.
Summary
Aurora Cannabis beats Cronos Group on 9 of the 16 factors compared between the two stocks.
Get Aurora Cannabis News Delivered to You Automatically
Sign up to receive the latest news and ratings for ACB and its competitors with MarketBeat's FREE daily newsletter.
This chart shows the number of new MarketBeat users adding ACB and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period.
Skip ChartThis chart shows the average media sentiment of TSE and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.
Skip Chart
Aurora Cannabis Competitors List
Related Companies and Tools